![]() ![]() | Generic Fosamax (Alendronate)Osteoporosis Drug | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Most popular quantity. Information About Generic Fosamax (Alendronate Sodium)What is Generic Fosamax (Alendronate Sodium)Working of Generic Fosamax (Alendronate Sodium)Generic Fosamax (Alendronate Sodium) Dosage or AdministrationPrecautions for Taking Generic Fosamax (Alendronate Sodium)Interaction of Generic Fosamax (Alendronate Sodium) with Other DrugsSide effects of Generic Fosamax (Alendronate Sodium)
Alendronate Sodium is generic equivalent of Fosamax, it is used for Treatment of osteoporosis in postmenopausal women; prevention of osteoporosis in postmenopausal women at risk of developing osteoporosis; treatment of osteoporosis in men; treatment of glucocorticoid-induced osteoporosis in men and women; treatment of Paget disease of the bone. What is Generic Fosamax (Alendronate Sodium)Generic Fosamax belong to calss Hormone/Bisphosphonates. Generic Fosamax Inhibits bone resorption and increases bone density. Generic Fosamax (Alendronate Sodium) Dosage or AdministrationOsteoporosis (Postmenopausal Women) ADULTS: PO Treatment: 70 mg once weekly or 10 mg once daily. Prevention: 35 mg once weekly or 5 mg once daily. Osteoporosis (Men) ADULTS: PO 10 mg once daily. Glucocorticoid-Induced Osteoporosis ADULTS PO 5 mg once daily. For postmenopausal women not receiving estrogen, 10 mg once daily. Paget Disease ADULTS: PO 40 mg once daily for 6 mo. Retreatment may be considered for patients who relapse after a 6-mo observation period. Precautions for Taking Generic Fosamax (Alendronate Sodium)Pregnancy: Category C. Lactation: Undetermined. Children: Safety and efficacy not established. Renal: Not recommended for patients with CrCl < 35 mL/min. GI Disorders: Not recommended for patients with upper GI problems. Hypocalcemia: Correct before starting alendronate. Nutrition: Maintain adequate calcium and vitamin D intake during alendronate therapy. Concomitant estrogen replacement therapy: Not recommended. Absorption: Food, beverages other than water, and medication inhibit absorption. Must be taken first thing in the morning with a full glass of water ³ 30 min before any food, beverages, or medications. Must remain sitting or standing for 30 min after taking. Interaction of Generic Fosamax (Alendronate Sodium) with Other DrugsFood: Absorption of alendronate is decreased by food. Liquids: Beverages other than water decrease absorption. Ranitidine: Increased alendronate absorption; clinical importance unknown. Calcium supplements, antacids: Decreased alendronate absorption. Aspirin: Risk of upper GI adverse effects is increased by concomitant use of aspirin and alendronate doses over 10 mg/day. Side effects of Generic Fosamax (Alendronate Sodium)CNS: Headache. GI: Abdominal pain; constipation; diarrhea; flatulence; esophageal
ulcer; dysphagia. OTHER: Musculoskeletal pain. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||